Anatomical and visual outcome of intravitreal bevacizumab (Avastin) in patients with diabetic macular edema.
Journal:
Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH
PMID:
28242886
Abstract
BACKGROUND: Intravitreal bevacizumab has been shown to be an effective treatment of diabetic macular edema.